| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A novel chemoradiation targeting stem and nonstem pancreatic cancer cells by repurposing disulfiram
|
Cong, Juan
|
|
|
409 |
C |
p. 9-19
|
artikel
|
| 2 |
Chronic lymphocytic leukemia with isochromosome 17q: An aggressive subgroup associated with TP53 mutations and complex karyotypes
|
Collado, Rosa
|
|
|
409 |
C |
p. 42-48
|
artikel
|
| 3 |
Editorial Board
|
|
|
|
409 |
C |
p. ii
|
artikel
|
| 4 |
HSF1 upregulates ATG4B expression and enhances epirubicin-induced protective autophagy in hepatocellular carcinoma cells
|
Zhang, Nan
|
|
|
409 |
C |
p. 81-90
|
artikel
|
| 5 |
MiR-127 and miR-376a act as tumor suppressors by in vivo targeting of COA1 and PDIA6 in giant cell tumor of bone
|
Herr, Ingrid
|
|
|
409 |
C |
p. 49-55
|
artikel
|
| 6 |
MITF suppression improves the sensitivity of melanoma cells to a BRAF inhibitor
|
Aida, Satoshi
|
|
|
409 |
C |
p. 116-124
|
artikel
|
| 7 |
Mutations of RNA splicing factors in hematological malignancies
|
Shukla, Girish C.
|
|
|
409 |
C |
p. 1-8
|
artikel
|
| 8 |
PAD1 promotes epithelial-mesenchymal transition and metastasis in triple-negative breast cancer cells by regulating MEK1-ERK1/2-MMP2 signaling
|
Qin, Hao
|
|
|
409 |
C |
p. 30-41
|
artikel
|
| 9 |
Pharmacological blockade of cholesterol trafficking by cepharanthine in endothelial cells suppresses angiogenesis and tumor growth
|
Lyu, Junfang
|
|
|
409 |
C |
p. 91-103
|
artikel
|
| 10 |
Role of cellular metabolism in regulating type I interferon responses: Implications for tumour immunology and treatment
|
Ahmed, Duale
|
|
|
409 |
C |
p. 20-29
|
artikel
|
| 11 |
SIRT1 suppresses colorectal cancer metastasis by transcriptional repression of miR-15b-5p
|
Sun, Li-Na
|
|
|
409 |
C |
p. 104-115
|
artikel
|
| 12 |
The two novel DLL4-targeting antibody-drug conjugates MvM03 and MGD03 show potent anti-tumour activity in breast cancer xenograft models
|
Wang, Shijing
|
|
|
409 |
C |
p. 125-136
|
artikel
|
| 13 |
TNF-related apoptosis-inducing ligand (TRAIL) for bone sarcoma treatment: Pre-clinical and clinical data
|
Gamie, Zakareya
|
|
|
409 |
C |
p. 66-80
|
artikel
|
| 14 |
Tyrphostin RG14620 selectively reverses ABCG2-mediated multidrug resistance in cancer cell lines
|
Wu, Chung-Pu
|
|
|
409 |
C |
p. 56-65
|
artikel
|
Tijdschrift beschrijving